Modus Therapeutics Holding AB (99Z) Financial Statements
Modus Therapeutics Holding AB Financial Overview
Modus Therapeutics Holding AB's market cap is currently $2.85M. The company's EPS TTM is $-0.18; its P/E ratio is -1.02; Modus Therapeutics Holding AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -18.17M | $ -15.84M | $ -16.40M | $ -18.01M | $ -20.69M |
| EBITDA | $ -18.17M | $ -15.84M | $ 2.00K | $ 0.00 | $ -20.69M |
| Net Income | $ -18.54M | $ -15.54M | $ -17.90M | $ -18.32M | $ -20.69M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 11.37M | $ 4.38M | $ 19.06M | $ 10.42M | $ 20.65M |
| Total Assets | $ 12.69M | $ 4.88M | $ 20.04M | $ 11.27M | $ 21.19M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 11.50M | $ 0.00 |
| Net Debt | $ -11.37M | $ -4.38M | $ -19.06M | $ 1.08M | $ -20.65M |
| Total Liabilities | $ 3.62M | $ 2.75M | $ 2.36M | $ 13.86M | $ 5.46M |
| Stockholders' Equity | $ 9.07M | $ 2.14M | $ 17.68M | $ -2.58M | $ 15.73M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.07M | $ -14.68M | $ -16.68M | $ -21.72M | $ -16.08M |
| Operating Cash Flow | $ -18.07M | $ -14.68M | $ -16.68M | $ -21.72M | $ -16.08M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -50.00K |
| Financing Cash Flow | $ 25.07M | $ 0.00 | $ 25.32M | $ 11.50M | $ 29.43M |
Currency in SEK
